NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients.
Patrick RossignolK DuarteE BressoÅsberg AM D DevignesNiclas ErikssonNicholas GirerdR GlerupA G JardineH HoldaasZ LamiralC LeroyZ MassyW MärzB KrämerP H WuR SchmiederI SoveriJ H ChristensenM SvenssonFaiez ZannadB FellströmPublished in: European heart journal open (2022)
Our findings suggest that NT-proBNP and SCF may help identify ESRD patients with respectively high and low CV risk, beyond classical clinical predictors and also point at novel pathways for prevention and treatment.